Companies: 48,874 Total Market Cap: 132469204852629.92

Zentiva S.A.

BVB-SCD
Pharmaceutical Preparations
Rank #11332
Market Cap 700.74 M
Volume 2,573
Price 1.01
Change (%) 2.26%
Country or region Romania Romania

Zentiva S.A.'s latest marketcap:

700.74 M

As of 05/20/2025, Zentiva S.A.'s market capitalization has reached $700.74 M. According to our data, Zentiva S.A. is the 11332th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 700.74 M
Revenue (ttm) 248.91 M
Net Income (ttm) 51.51 M
Shares Out 697.02 M
EPS (ttm) 0.07
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/20/2025

Zentiva S.A.'s yearly market capitalization.

Zentiva S.A. has seen its market value grow from 2.02 B RON to 3.15 B RON since 2020, representing a total increase of 55.86% and an annual compound growth rate (CAGR) of 12.07%.
Date Market Cap(RON) Change (%)
11/20/2024 3.15 B 54.79%
12/29/2023 2.04 B 50.52%
12/30/2022 1.35 B -20.49%
12/30/2021 1.70 B -15.86%
12/28/2020 2.02 B

Company Profile

About Zentiva S.A.

Zentiva S.A. is a pharmaceutical company specializing in the production and marketing of human-use medicines and preparations. Operating in Romania and internationally, the company focuses on delivering high-quality, affordable healthcare solutions.

Therapeutic Areas

Zentiva develops pharmaceutical products across a broad range of therapeutic areas, including:

  • Cardiovascular diseases
  • Anti-inflammatory and pain relief
  • Urology
  • Blood diseases
  • Gastrointestinal and metabolic disorders
  • Central nervous system
  • Infections
  • Respiratory systems

Generic Medicines

The company is a key player in the development of generic medicines, providing cost-effective alternatives to original pharmaceutical products without compromising quality. These solutions help make treatments accessible to a wider patient base.

Additional Offerings

Beyond pharmaceuticals, Zentiva supplies educational materials for both healthcare professionals and patients, supporting informed medical decisions and treatment adherence.

Company Background

Originally founded in 1962 as Sicomed S.A., the company rebranded to Zentiva S.A. in January 2006. Headquartered in Bucharest, Romania, Zentiva operates as a subsidiary of Zentiva Group a.s.

Frequently Asked Questions

As of 05/20/2025, Zentiva S.A. (including the parent company, if applicable) has an estimated market capitalization of $700.74 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Zentiva S.A. global market capitalization ranking is approximately 11332 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Romania
Founded 1962
IPO Date n/a
Employees 963
CEO Simona Cocos
Sector
Industry Pharmaceutical Preparations
Address Bvd. Theodor Pallady, nr. 50.
Bucharest, 032266
Romania
Website https://www.zentiva.ro
People Also Watch
Ipsen S.A.
138.04 2.26%
Krka, d. d.
209.10 2.26%
BUD-RICHTER
29.31 2.26%
Hugel
246.71 2.26%